Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Tue., Feb. 7, 10:22 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #25 of 100 |
Slide #25. Cumberland Pharmaceuticals — Vaprisol from Astellas Pharma US, Inc.
Acquirer:
Cumberland Pharmaceuticals (NASDAQ:CPIX)
Acquiree:
Vaprisol from Astellas Pharma US, Inc.
Details:
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
Open the CPIX Page at The Online Investor »
|
|||||||||||||||||||||
Open the CPIX Page at The Online Investor (in a new window) »
 Free CPIX Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: CPIX Stock Forecast Based on Zacks ABR data; powered by Xignite |
